The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes

Adiponectin exerts renoprotective effects against diabetic nephropathy (DN) by activating the AMP-activated protein kinase (AMPK)/peroxisome proliferative-activated receptor–α (PPARα) pathway through adiponectin receptors (AdipoRs). AdipoRon is an orally active synthetic adiponectin receptor agonist...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Am Soc Nephrol
Autors principals: Kim, Yaeni, Lim, Ji Hee, Kim, Min Young, Kim, Eun Nim, Yoon, Hye Eun, Shin, Seok Joon, Choi, Bum Soon, Kim, Yong-Soo, Chang, Yoon Sik, Park, Cheol Whee
Format: Artigo
Idioma:Inglês
Publicat: American Society of Nephrology 2018
Matèries:
Basic Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5875945/
https://ncbi.nlm.nih.gov/pubmed/29330340
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2017060627
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars